Metaclinic maintains a narrowly scoped healthcare software product line centered on the NanoVault application, which exhibits vulnerability signals rooted in web application input handling. The recurring weakness classes—code injection and cross-site scripting—reflect common risks in web-facing healthcare systems where input validation and output encoding are critical controls. Current severity, exploitation activity, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Metaclinic over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2025-8535CRITICAL A vulnerability, which was classified as problematic, has been found in cronoh NanoVault up to 1.2.1. This issue affects the function executeJavaScript of the file /main.js of the | Aug 5, 2025 | 9.0 | 26 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Metaclinic.
Media articles that mention a CVE ID that affects a product developed by Metaclinic — matched by CVE ID, not by vendor name.